The FDA pulls key DEI initiative for cancer studies from its website

The FDA pulls key DEI initiative for cancer studies from its website

The Food and Drug Administration has removed webpages about diversity and inclusion in clinical trials for cancer drugs.The page for Project Equity, a 2021 initiative launched by the FDA’s Oncology Center of Excellence to ensure that cancer drugs were evaluated for approval based on data from a diverse group of study participants, has gone dark.The program aimed to develop policies to make clinical trials for treatments more accessible to people…

FDA purges material on clinical trial diversity from its site, showing stakes of Trump DEI ban

Following the Trump administration's DEI ban, the FDA's move to scrub webpages has ensnared many pages focused on ensuring diversity in drug trials.

BLK ALERTS - The FDA pulls key DEI initiative for cancer studies from its website

A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the agency’s website, as the Trump administration halts DEI initiatives. (Image credit: Sarah Silbiger)

Trump Administration strips FDA DEI Health Initiatives, harming clinical research and patient care

WASHINGTON, D.C. — The Trump Administration has purged Food and Drug Administration (FDA) website pages about diversity, equity and inclusion in the clinical trials used to test drugs and medical devices, as reported by STAT.The pages included draft guidance on clinical trial diversity, a discussion paper about diversity in clinical trials from the Center for Devices and Radiological Health and the equity initiative at the Oncology Center of Exc…